Educational Administration: Theory and Practice

Résumé

Background: The incidence of multiple myeloma (MM), a malignancy that affects plasma cells, is increasing in developed countries. Vitamin D (VD) status is a modifiable factor that may lower the risk of cancer by modulating cell proliferation, apoptosis, invasion, and metastasis by attaching to a particular receptor, the vitamin D receptor (VDR). The study aims: to assess serum Vitamin D levels, urea, creatinine, calcium, phosphorus, uric acid and hemoglobin, among Sudanese individuals diagnosed with MM. Methods: This is a case control study, where 50 patients and 50 healthy age matched controls were enrolled after informed consent. Blood (serum) samples were analyzed for Vitamin D level and renal profile using a fully automated cobas 6000 & e 601 (Roch Germany). Hemoglobin levels in whole blood were determined by the Sysmex KX21 autoanalyzer. Results: vitamin D deficiency was common in multiple myeloma patients. There was a significant difference between the two groups p-value= 0.043. A ten-fold increase to have MM was found among the first quartile vitamin D level ≤11.45 IU/L (OR= 10.7). Urea, creatinine, calcium, phosphorus, uric acid and hemoglobin revealed a significant difference between patient and control. No statistically significant differences in the means of renal disorder markers across the four quartiles among MM cases. Creatinine, phosphate, and calcium levels showed a significant association with vitamin D deficiency. Conclusion: A significant association between vitamin D deficiency and the risk of MM. Individuals with lowest vitamin D levels exhibited a ten-fold increase to have MM.

Citer ce document

Accès au document

Texte intégral en lecture en ligne, réservé aux abonnés SPHAERO et aux membres de l'institution. Se connecter

Auteur(s)

Statistiques

Consultations : 1

Téléchargements : 0